Yu-hong Li. "Sintilimab plus bevacizumab, oxaliplatin, and capecitabine as perioperative therapy in microsatellite-stable, resectable colorectal cancer liver metastases: An open-label, single-arm, phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3586